Deciphera Pharmaceuticals, Inc. Banner Image

Deciphera Pharmaceuticals, Inc. has reached its limit for free report views

Work for Deciphera Pharmaceuticals, Inc.? Upgrade Your Profile and unlock all your annual reports.

Deciphera Pharmaceuticals, Inc.

  • Ticker DCPH
    Exchange NASDAQ More
  • Industry Biotechnology More
  • Sector Healthcare More
Deciphera Pharmaceuticals, Inc. Logo Image
  • 201-500 Employees
  • Based in Waltham, Massachusetts
Deciphera is a biopharmaceutical company focused on discovering, developing and commercializing important new medicines to improve the lives of people with cancer. They are leveraging their proprietary switch-control kinase inhibitor platform and deep expertise in kinase biology to develop a broad portfolio of innovative medicines. In addition to advancing multiple product candidates fromMore their platform in clinical studies, QINLOCKTM is Deciphera’s FDA-approved switch-control kinase inhibitor for the treatment of fourth-line gastrointestinal stromal tumor (GIST). QINLOCK is also approved for fourth-line GIST in Canada and Australia.
Deciphera Pharmaceuticals, Inc.

Most Recent Annual Report

Deciphera Pharmaceuticals, Inc. MOST RECENT 2019 Form 10K

Report Locked. Deciphera Pharmaceuticals, Inc. has reached its limit for free report views.

Older/Archived Annual Reports